Dr. Kohli's JointTone
Natural health product licensed in Canada
- Licence holder
- Dr. Kohli's Bio-Balance Remedies Inc.
- NPN or DIN-HM
- 80076831
- Status
- Active licence
- Licence date
- 20 April 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Boswellia serrata Source : Gum oleoresin Potency : 65 % Boswellic acids | 205 milligramme | Not calculated |
| Curcuma longa Source : Rhizome Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 2,000 milligramme | 200 milligramme | Not calculated |
| Zingiber officinale Source : Rhizome | 50 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Dr. Kohli's JointTone is especially formulated to relieve joint pain and swelling associated with osteoarthritis of the knee. The formulation is traditionally used in Ayurveda as an anti-inflammatory to help relieve joint pain.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding or if symptoms worsen.
- Effets indésirables connus
Some people may experience mild gastrointestinal disturbances such as diarrhoea, abdominal pain, heartburn, nausea and vomiting; in which case, discontinue use.
Source
Official Health Canada record, licence 80076831
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.